Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

TECLISTAMAB-CQYV vs TEDUGLUTIDE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

TECLISTAMAB-CQYV vs TEDUGLUTIDE: Safety Overview

Metric TECLISTAMAB-CQYV TEDUGLUTIDE
Total FAERS Reports 1,592 8,774
Deaths Reported 338 788
Death Rate 21.2% 9.0%
Hospitalizations 395 5,977
Average Patient Age 68.9 yrs 50.6 yrs
% Female Patients 49.5% 62.0%
FDA Approval Date N/A Dec 21, 2012
Manufacturer N/A Takeda Pharmaceuticals America, Inc.
Route N/A SUBCUTANEOUS
Marketing Status Prescription Prescription